Bioethics Stock Today
| BOTH Stock | USD 0.01 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressHigh
|
Bioethics is trading at 0.0051 as of the 27th of February 2026. This is a No Change since the beginning of the trading day. The stock's open price was 0.0051. Bioethics has more than 66 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 29th of November 2025 and ending today, the 27th of February 2026. Click here to learn more.
It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States. The company has 1.14 M outstanding shares. More on Bioethics
Moving against Bioethics Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bioethics Pink Sheet Highlights
| CEO | Mark Scharmann |
| Business Concentration | Shell Companies, Financial Services (View all Sectors) |
Bioethics [BOTH] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 295.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioethics's market, we take the total number of its shares issued and multiply it by Bioethics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bioethics conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 1.14 M outstanding shares.
Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations.
Check Bioethics Probability Of Bankruptcy
Ownership AllocationBioethics shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 88.53 percent of Bioethics outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event.
Check Bioethics Ownership Details
Bioethics Stock Against Markets
Bioethics Pink Sheet Analysis Notes
About 89.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.09. Bioethics last dividend was issued on the 2nd of November 2020. The entity had 1:10 split on the 2nd of November 2020. It intends to seek, investigate, and if warranted acquire an interest in a business opportunity. The company was incorporated in 1990 and is based in Ogden, Utah. Bioethics is traded on OTC Exchange in the United States.The quote for Bioethics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Bioethics please contact Mark Scharmann at 801 399 3632.Bioethics Investment Alerts
| Bioethics generated a negative expected return over the last 90 days | |
| Bioethics has some characteristics of a very speculative penny stock | |
| Bioethics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (107.18 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Bioethics currently holds about 554 in cash with (27.48 K) of positive cash flow from operations. | |
| Roughly 89.0% of the company shares are held by company insiders |
Bioethics Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 295.15 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bioethics's market, we take the total number of its shares issued and multiply it by Bioethics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
Bioethics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Bioethics Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Bioethics Tanh Of Price Series is a hyperbolic price transformation function.
Bioethics Outstanding Bonds
Bioethics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Bioethics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Bioethics bonds can be classified according to their maturity, which is the date when Bioethics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BIO 33 15 MAR 27 Corp BondUS090572AR99 | View | |
| BIO 37 15 MAR 32 Corp BondUS090572AQ17 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bioethics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Other Information on Investing in Bioethics Pink Sheet
Bioethics financial ratios help investors to determine whether Bioethics Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bioethics with respect to the benefits of owning Bioethics security.